During the past decade, Hedi Chaker University Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hedi Chaker University Hospital" are "Amyloidosis" (1 trials), "Hyperoxaluria, Primary" (1 trials) and "Primary Hyperoxaluria" (1 trials). Many other conditions were trialed in "Hedi Chaker University Hospital" in a lesser frequency.

Most popular intervention types in "Hedi Chaker University Hospital" are "Biological" (2 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "KIACTA (eprodisate disodium)" (1 trials), "Oxabact OC5 - Oxalobacter formigenes HC-1" (1 trials) and "Oxabact OC5 - Oxalobacter formigenes Strain HC-1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hedi Chaker University Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Hedi Chaker University Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hedi Chaker University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hedi Chaker University Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".